Chinese researchers report successful hepatitis E vaccine
(HealthDay)—A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers.
Mar 4, 2015
0
32
(HealthDay)—A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers.
Mar 4, 2015
0
32
Hepatitis C virus infection is a common cause of liver disease and of liver cancer in the United States. Through a new study that explores one aspect of how the virus hijacks host cell machinery to replicate itself, UNC Lineberger ...
Feb 23, 2015
0
9
One of the most common causes of hepatitis A (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not all patients are cured by the treatment currently ...
Dec 23, 2014
0
0
A new toolkit on screening for chronic viral hepatitis seeks to raise awareness, improve knowledge and motivate public health professionals in Europe to take action. Knowledge and understanding of what works in screening ...
Dec 12, 2014
0
0
New, significantly improved hepatitis C drugs have revolutionized how the disease is treated, but they are also expensive. One such drug, sofosbuvir, costs more than $7,000 a week for 12 weeks of treatment.
Oct 20, 2014
0
0
Nursing home infection rates are on the rise, a study from Columbia University School of Nursing found, suggesting that more must be done to protect residents of these facilities from preventable complications. The study, ...
Oct 8, 2014
0
0
A high alcohol intake is linked to a heightened risk of human papillomavirus infection among men, suggests research in the journal Sexually Transmitted Infections. The findings seem to be independent of other risk factors ...
Oct 2, 2014
1
0
The world can beat the cancer-causing disease hepatitis if it raises its game, but treatment programmes need to go hand in hand with those tackling the likes of HIV, experts said Thursday.
Jul 24, 2014
0
0
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C.
Jul 19, 2014
0
0
A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that ...
Jul 2, 2014
0
0